Stockscreener 앱 받기
0.622
2.03%
-0.0129
시간 외 거래:
.63
0.008
+1.29%
전일 마감가:
$0.6349
열려 있는:
$0.645
하루 거래량:
768.18K
Relative Volume:
0.22
시가총액:
$44.75M
수익:
-
순이익/손실:
$-86.08M
주가수익비율:
-0.2883
EPS:
-2.1574
순현금흐름:
$-72.06M
1주 성능:
-26.83%
1개월 성능:
-24.61%
6개월 성능:
-52.15%
1년 성능:
-18.76%
1일 변동 폭
$0.6122
$0.673
1주일 범위
$0.6122
$0.8622
52주 변동 폭
$0.3234
$2.79
Io Biotech Inc Stock (IOBT) Company Profile
명칭
Io Biotech Inc
전화
(457) 070-2980
주소
OLE MAALOES VEH 3, COPENHAGEN
IOBT을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
IOBT
Io Biotech Inc
|
0.622 | 45.68M | 0 | -86.08M | -72.06M | -2.1574 |
|
VRTX
Vertex Pharmaceuticals Inc
|
447.38 | 114.05B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
748.71 | 78.80B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
396.04 | 51.80B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
847.05 | 53.08B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
166.55 | 42.33B | 447.02M | -1.18B | -906.14M | -6.1812 |
Io Biotech Inc Stock (IOBT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-30 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2025-09-30 | 다운그레이드 | TD Cowen | Buy → Hold |
Io Biotech Inc 주식(IOBT)의 최신 뉴스
How strong is IO Biotech Inc. stock balance sheetAnalyst Upgrade & Fast Gaining Stock Strategy Reports - Улправда
Why IO Biotech Inc. stock could outperform in 2025July 2025 Big Picture & Short-Term High Return Strategies - Улправда
Will IO Biotech Inc. stock pay special dividends2025 Price Action Summary & Short-Term High Return Ideas - Улправда
Shorts Report: Will IO Biotech Inc. stock pay special dividends2025 Bull vs Bear & Free Growth Oriented Trading Recommendations - Улправда
Why hedge funds are buying IO Biotech Inc. stockJuly 2025 Review & Risk Managed Trade Strategies - Улправда
IO Biotech, Inc. (NASDAQ:IOBT) Receives $6.33 Average PT from Analysts - Defense World
IO Biotech reports promising 5-year melanoma vaccine data - Investing.com
IO Biotech Publishes Five-Year Results from MM1636 Trial Showing Potential of IO102-IO103 in Metastatic Melanoma Treatment - Quiver Quantitative
IO Biotech (NASDAQ: IOBT) 5-year data show 60-month OS, >53-month responses - Stock Titan
Surprises Report: Will IO Biotech Inc. stock reach all time highs in 2025 - moha.gov.vn
IO Biotech, Inc. (NASDAQ:IOBT) Receives Consensus Recommendation of "Hold" from Analysts - MarketBeat
IO Biotech (NASDAQ:IOBT) Stock Rating Lowered by Wall Street Zen - MarketBeat
Nothing is Better Than IO Biotech Inc (IOBT) stock at the moment - Setenews
What margin trends mean for IO Biotech Inc stock2025 Winners & Losers & AI Powered Trade Plan Recommendations - BỘ NỘI VỤ
IO Biotech (IOBT) Stock Analysis Report | Financials & Insights - Benzinga
How does IO Biotech Inc (IOBT) change from a tortoise to a hare? - Setenews
Will IO Biotech Inc. stock reach all time highs in 2025July 2025 Levels & Growth Focused Stock Reports - moha.gov.vn
Research Recommendations For IO Biotech Inc (IOBT): Here is What You Should Know - fostersleader.com
Analyst Downgrade: How IO Biotech Inc. stock benefits from strong dollarJuly 2025 Movers & Free Growth Oriented Trading Recommendations - moha.gov.vn
Aug Wrap: What margin trends mean for IO Biotech Inc. stockJuly 2025 Decliners & Real-Time Volume Analysis Alerts - moha.gov.vn
IO Biotech Announces Participation in Upcoming December Investor Conferences - The Manila Times
IO Biotech (Nasdaq: IOBT) to Join Evercore, Piper Sandler December Investor Events - Stock Titan
IOBTRemeasuring Biotech Pipelines: The Valuation Signal Investors Have Been Waiting For - mx.advfn.com
It makes sense and dollars to buy IO Biotech Inc (IOBT) stock - Setenews
IO Biotech (NASDAQ:IOBT) Stock Rating Upgraded by Wall Street Zen - Defense World
Ligand Pharmaceuticals (NASDAQ:LGND) and IO Biotech (NASDAQ:IOBT) Financial Review - Defense World
IO Biotech announces resignation of chief accounting officer and new appointment - Investing.com Australia
IO Biotech Announces Resignation of Chief Accounting Officer - MSN
IO Biotech announces resignation of chief accounting officer and new appointment By Investing.com - Investing.com South Africa
IO Biotech Announces Management Changes - TradingView
[8-K] IO Biotech, Inc. Reports Material Event | IOBT SEC FilingForm 8-K - Stock Titan
IO Biotech, Inc. Announces Executive Changes - MarketScreener
Can IO Biotech Inc. stock withstand economic slowdown2025 Retail Activity & Risk Controlled Daily Trade Plans - newser.com
IO Biotech’s Q3 2025: Progress in Cancer Vaccine Trials - MSN
Remeasuring Biotech Pipelines: The Valuation Signal Investors Have Been Waiting For - The Spec
Piper Sandler reiterates Overweight rating on IO Biotech stock By Investing.com - Investing.com South Africa
Is IO Biotech Inc. stock entering bullish territoryJuly 2025 Review & Fast Gaining Stock Reports - newser.com
Is IO Biotech Inc. stock a top momentum playWeekly Stock Analysis & Daily Price Action Insights - newser.com
IO Biotech, Inc. (IOBT) Upgraded to Buy: Here's Why - MSN
Will IO Biotech Inc. stock deliver long term returns2025 Support & Resistance & High Conviction Buy Zone Picks - newser.com
Piper Sandler reiterates Overweight rating on IO Biotech stock - Investing.com India
IO Biotech Inc. (IOBT) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Is IO Biotech Inc. stock safe for conservative investorsPortfolio Return Summary & Reliable Volume Spike Alerts - newser.com
IO Biotech Presents at Jefferies Global Healthcare Conference - MSN
IO Biotech Inc (IOBT) is looking forward to a strong quarter - Setenews
IO Biotech, Inc. Updates on Cylembio Phase 3 Trial Results - TradingView
Io Biotech Inc (IOBT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.31%
0.33%
자본화:
|
볼륨(24시간):